| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| scAAV1.tMCK.NTF3 | Phase 2 Clinical | Nationwide Children'S Hospital, Sarepta Therapeutics Inc | Charcot-Marie-Tooth Disease | Details | |
| LEVI-04 | LEVI-04; p75NTR-Fc | Phase 2 Clinical | Levicept | Arthritis; Joint Diseases; Musculoskeletal Diseases; Osteoarthritis; Osteoarthritis, Knee; Pain; Rheumatic Diseases | Details |